The present subject matter relates to dressings made from films which are typically oxygen permeable, and have high moisture vapor permeability but which are impermeable to liquid water and bacteria. The dressings include a label strip that can include text, indicia, logos, or other markings. The subject matter also relates to methods of producing such dressings and similar products.
Wound dressings made with composite layers of film and adhesive which have high moisture vapor transmission rates are well known in the art. These dressings are used in many applications and are beneficial in that they are impervious to bacteria and liquid water but yet allow oxygen to penetrate the dressing from the ambient atmosphere and allow moisture from the skin of the patient to escape from beneath the dressing.
In order to obtain the desired moisture vapor transmission rate, the dressings are made from extremely thin films of polyurethane or of other polymeric materials which have the desired moisture vapor transmission properties. These films are extremely thin, typically less than 10 mils, and are very flexible, limp, and flimsy because of their thinness. These characteristics allow the dressing to be applied to the varying contours of the human body but also present difficulties in the application of the dressing to a patient. The dressings are typically provided with a release sheet covering the adhesive surface of the dressing. The release sheet is removed from the dressing when the dressing is applied to the patient. The thinness of the film and its flexibility allows the film to turn over onto itself during attempts to apply the film dressing to a patient. The film is similar in this property to polyvinylidene chloride film household wrap. When a portion of the adhesive surface of the film touches other portions of the adhesive surface, the film dressing sticks to itself and makes it extremely difficult to separate the adhered portions and then apply to the patient.
In order to overcome this problem, film dressings of this type have been provided with adhesive-free tabs at opposite ends of the film. In some products there is a reinforcing member at the tab ends to provide a grasping or holding surface to be used to apply the dressings to a patient.
Prior to or after application of a dressing or other adhesive thin film article to a patient, it may in certain applications be necessary to mark or otherwise apply text or information to the dressing. For example, for certain dressings, date information associated with the article may be included. In other instances, it may be desirable to include patient information or treatment information directly on the dressing or article. Although a medical practitioner could in certain instances, write or otherwise apply markings along an outer face of the dressing that practice may be undesirable. The outer face of the polyurethane film or other polymeric material may be difficult to write upon. Other parameters may detrimentally impact ability to write or apply markings on the dressing.
Accordingly, a need exits for a dressing or thin film article which may readily receive text or other markings or indicia.
The difficulties and drawbacks associated with previously known dressings are addressed in the present articles and related methods.
In one aspect, the present subject matter provides a dressing comprising a dressing film defining an inner face and an oppositely directed outer face. The dressing also comprises a support film disposed on at least a portion of the outer face of the dressing. The dressing additionally comprises an adhesive disposed on at least a portion of the inner face of the dressing film. And, the dressing also comprises a label strip adhered to the outer face of the dressing film. The label strip has an outer face adapted to receive printing, marking, or other indicia.
As will be realized, the subject matter described herein is capable of other and different embodiments and its several details are capable of modifications in various respects, all without departing from the claimed subject matter. Accordingly, the drawings and description are to be regarded as illustrative and not restrictive.
The present subject matter provides dressings which include one or more label strips. The label strip can include text, indicia, logos, or other markings. The label strip is incorporated into a transparent cover dressing such as a window dressing, or any dressing using a thin polymeric film (such as for example polyurethane) having an adhesive on a face of the film, for contacting skin. In certain embodiments of the present subject matter, the label strip is attached to an outer face of the transparent film. Attachment can be accomplished by a variety of techniques, however, attachment is typically achieved by adhesive. After application of the dressing to skin, the label remains attached to the outer face of the transparent film. Prior to (or after) application, writing or other operations can be performed to provide text or information on the label strip, which will remain with the dressing even after application.
The dressings generally comprise (i) an outer support film, (ii) one or more handling tabs attached to the support film, (iii) a thin dressing film, (iv) one or more adhesives on a face of the dressing film, (v) a liner covering the one or more adhesives prior to use or application of the dressing, and (vi) one or more label strips incorporated in the dressing and typically disposed on an outer face of the dressing film.
Details as to each of the components of the dressings are as follows.
Transparent or translucent film materials are particularly intended as supporting films. However, opaque or non-transparent paper or film materials can be used alternatively. Useful as supporting films are particularly those films that are manufactured from polyester, polyethylene, polypropylene, polyvinylchloride, polystyrene, polyamide, polycarbonate, cellulose ester, ethylene vinyl acetate, polyvinyl acetate, polyvinyl alcohol and/or combinations thereof. Particularly preferred are supporting films from polyester or polyethylene or polypropylene. The present subject matter also includes the use of paper or paper-based materials for the support component. Combinations of polymeric and paper materials can also be used. It has been proven to be particularly preferable when the thickness of the supporting films are adjusted to a thickness of about 15 to about 80 μm, particularly from about 20 to about 60 μm and especially from about 20 to about 40 μm.
One or more optional handling tab(s) may be incorporated into the dressing and is provided either partially or entirely along an edge of the dressing and/or the support film. Handling tabs can be provided on the support film, the release liner, or both. When provided on the support film, the handling tab can be in the form of an integral extension or projection of the support film. In certain versions, the handling tab is arranged near the center of a side edge of the dressing. However, the handling tab can have various other configurations and arrangements. Also, the location can be as desired and more than one handling tab can be provided.
The dressing film is preferably made of a thin, flexible, conformable, resilient, supple, limp or flimsy material that can flex or bend to conform to irregular surfaces or contours, such as those of anatomical body parts. Preferably, dressing film is sufficiently resilient to stretch or flex in response to movement or flexing of the dressing support film and to conform to the dressing support film when the dressing support film returns to an unflexed condition. The dressing film is preferably transparent or substantially transparent to permit visualization through the dressing film and/or of the support film. Or, the dressing film can be opaque. The dressing film can be air permeable to allow oxygen to penetrate the dressing as well as moisture vapor permeable to allow moisture from the skin surface to escape through the dressing, and the dressing film can be liquid, air and bacteria impermeable. Non limiting examples of materials suitable for the dressing film include polymeric materials, such as polyurethane, copolyester, elastomeric polyester, polyethylene, blends of polyurethane and polyester, chlorinated polyethylene, styrene/butadiene block copolymers and polyvinyl chloride, formed into continuous films or sheets by casting, extrusion or other processes. The dressing film can have various sizes and configurations dependent on the surfaces to which the dressing is to be applied. The dressing film may have a square or rectangular peripheral configuration with rounded or radiused corners. The present subject matter includes nearly any shape for the dressing film. The dressing film preferably has a minimal thickness, typically in the range of 0.0005 inch to 0.004 inch, preferably about 0.0015 inch, with conformability of the dressing increasing with decreasing thickness of the dressing film.
Adhesive is provided on a skin contacting side or face of the dressing film to cover at least the entire area circumscribed by the final dressing portion and, preferably, for ease of manufacturing adhesive covers the entire area of face of the dressing film including a peripheral backing portion. Adhesive can be provided on a face of the dressing film in many various ways including solvent spreading, spraying, coating and extrusion, for example, and the adhesive can be applied directly to the dressing film or indirectly via a carrier sheet. The adhesive utilized is preferably a pressure sensitive, skin contact adhesive that is preferably hypo-allergenic and non-irritating to skin. Representative non-limiting examples of materials suitable for the adhesive include acrylate copolymers, such as copolymers of 2-ethylhexylacrylate and vinyl acetate with or without a cross-linking agent, water based adhesives and hot melt adhesives, for example. If desired, various medicaments and/or antimicrobial agents can be included in the adhesive to promote healing and inhibit infection. The adhesive is preferably applied on a face of the dressing film in a thin layer, such as on the order of 0.001 inch to 0.010 inch in thickness or greater (according to the desired application), sufficient to obtain adequate skin adhesion without impairing the air and moisture vapor transmission characteristics of the dressing. Preferably, the adhesive is an acrylic adhesive.
Various materials can be utilized for the release liner including conventional smooth surface paper materials, polyester films and polyolefin films of the type typically utilized as release liners, such as, for example, kraft paper, polyethylene, polypropylene, polyester and composites thereof. In certain applications, the release liner is sufficiently thick, i.e., on the order of 0.004 inch to 0.0075 inch in thickness or higher, to rigidify a backing sheet prior to use. The release liner is preferably sufficiently rigid and/or thick to typically maintain a flat configuration. However, the release liner can have some flexibility to bend, flex or deform in response to external pressure. Depending on the material utilized for the release liner, the surface can be coated with a release agent, such as fluorochemicals or silicone, for example, to facilitate release of the liner portion from the adhesive of the final dressing. It will be appreciated that the material utilized for the release liner, with or without a release agent, can be varied to achieve a desired bond or tenacity of adhesion between the release liner and the adhesive and that the bond or tenacity of adhesion can be selected such that manual removal or peeling away of the liner portion from the backing sheet can be accomplished with a gentle pressure or pulling force and without damage to or impairment of the dressing.
The liner can be a single panel liner or include multiple components or panels to form a liner assembly.
A wide range of materials can be used for the label strips that are associated with the dressings. In certain embodiments, the label strips are formed from paper or paper based materials. However, the present subject matter includes forming the label strips from polymeric materials. It is also contemplated that the label strips can be formed from combinations of paper and polymeric materials and be in the form of composite materials. The present subject matter also includes forming the label strips with one or more regions or layers of paper material(s) and one or more regions or layers of polymeric materials. Furthermore, one or both faces of the label strip and particularly a print-receiving face can be coated with a print-receptive topcoat to promote ink adherence or ink “wet-out.” Moreover, one or both faces of the label strip could be subjected to a surface treatment operation such as corona treatment or plasma treatment.
The label strip can also be coated with a release coating so that an adhesive coated portion of the handling tab can extend over the label strip. This configuration provides extra support to the dressing on application (and before removal of the support layer and associated handling tab). In this case the release coating is chosen to prevent permanent or strong adhesion of the handling tab and to provide significant “wet out” for the ink to allow writing/printing on the tab.
The one or more label strip(s) are typically disposed on an outer face of the dressing film. The label strip(s) can be secured to the dressing film such as by adhesive. The label strip(s) in certain versions of the dressings, are provided immediately alongside a recessed side edge of a support film. In particular versions of the dressings, the label strip(s) are positioned under the handling tab(s). And in specific versions of the present subject matter, the label strip(s) are disposed between a handling tab the dressing film, and also immediately alongside an edge of a support film. However, it will be understood that the present subject matter includes a wide range of arrangements, configurations, and variations of the dressings described herein.
Many other benefits will no doubt become apparent from future application and development of this technology. For example, the label strip can add additional bulk to the limp flimsy film to facilitate removal of the dressing from the skin after use. Due to the low caliper of the dressings it is typically very difficult to get a starting point for removal. The extra thickness and stiffness at the label strip position can significantly assist or promote removal efforts.
All patents, published applications, and articles noted herein are hereby incorporated by reference in their entirety.
As described hereinabove, the present subject matter solves many problems associated with previous strategies, systems and/or devices. However, it will be appreciated that various changes in the details, materials and arrangements of components, which have been herein described and illustrated in order to explain the nature of the present subject matter, may be made by those skilled in the art without departing from the principle and scope of the claimed subject matter, as expressed in the appended claims.
The present application is a 371 of International Patent Application No. PCT/US2014/025549 which was published in English on Sep. 25, 2014 and claims the benefit of U.S. Provisional Application No. 61/787,908 filed Mar. 15, 2013, both of which are incorporated herein by reference in their entireties.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2014/025549 | 3/13/2014 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/151355 | 9/25/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2736721 | Dexter | Feb 1956 | A |
4199567 | Rankin | Apr 1980 | A |
4310509 | Berglund et al. | Jan 1982 | A |
4434181 | Marks, Sr. et al. | Feb 1984 | A |
4460369 | Seymour | Jul 1984 | A |
4600001 | Gilman | Jul 1986 | A |
4753232 | Ward | Jun 1988 | A |
4941882 | Ward et al. | Jul 1990 | A |
4990144 | Blott | Feb 1991 | A |
5018516 | Gilman | May 1991 | A |
5069907 | Mixon et al. | Dec 1991 | A |
5214119 | Leir et al. | May 1993 | A |
5270358 | Asmus | Dec 1993 | A |
5322695 | Shah et al. | Jun 1994 | A |
5340581 | Tseng et al. | Aug 1994 | A |
5382451 | Johnson et al. | Jan 1995 | A |
5389376 | Duan et al. | Feb 1995 | A |
5441741 | Cheong | Aug 1995 | A |
5614310 | Delgado et al. | Mar 1997 | A |
5686096 | Khan et al. | Nov 1997 | A |
5702721 | Horstmann et al. | Dec 1997 | A |
5717005 | Richardson | Feb 1998 | A |
5763412 | Khan et al. | Jun 1998 | A |
5908693 | Delgado et al. | Jun 1999 | A |
6043406 | Sessions | Mar 2000 | A |
6228354 | Jeng | May 2001 | B1 |
6455086 | Trinh et al. | Sep 2002 | B1 |
6458341 | Rozzi et al. | Oct 2002 | B1 |
6495158 | Buseman et al. | Dec 2002 | B1 |
6518359 | Clemens et al. | Feb 2003 | B1 |
6565873 | Shefer et al. | May 2003 | B1 |
6589562 | Shefer et al. | Jul 2003 | B1 |
6599525 | Scamilla Aledo et al. | Jul 2003 | B2 |
6642304 | Hansen et al. | Nov 2003 | B1 |
6733745 | Rozzi et al. | May 2004 | B2 |
6742522 | Baker | Jun 2004 | B1 |
6844306 | Werle et al. | Jan 2005 | B2 |
6893655 | Flanigan et al. | May 2005 | B2 |
7160976 | Luhmann et al. | Jan 2007 | B2 |
7674473 | Falder et al. | Mar 2010 | B2 |
7683216 | Dubois et al. | Mar 2010 | B2 |
7704523 | Serafica et al. | Apr 2010 | B2 |
7824122 | Flores et al. | Nov 2010 | B2 |
8623935 | Hobbs et al. | Jan 2014 | B2 |
8969649 | Leibowitz et al. | Mar 2015 | B2 |
9101134 | Huang et al. | Aug 2015 | B2 |
9278155 | Asmus et al. | Mar 2016 | B2 |
9346981 | Wibaux et al. | May 2016 | B2 |
9592161 | Rule et al. | Mar 2017 | B2 |
9764059 | Wibaux et al. | Sep 2017 | B2 |
9801902 | Smith et al. | Oct 2017 | B2 |
10329384 | Hansen et al. | Jun 2019 | B2 |
10456498 | Wibaux | Oct 2019 | B2 |
20020018814 | Werle et al. | Feb 2002 | A1 |
20020072480 | Werle et al. | Jun 2002 | A1 |
20030077316 | Nichols et al. | Apr 2003 | A1 |
20030212005 | Petito | Nov 2003 | A1 |
20040009202 | Woller | Jan 2004 | A1 |
20040063792 | Khera et al. | Apr 2004 | A1 |
20040109869 | Glenn et al. | Jun 2004 | A1 |
20040170794 | Verhaert | Sep 2004 | A1 |
20040241214 | Kirkwood et al. | Dec 2004 | A1 |
20050049365 | Cleary et al. | Mar 2005 | A1 |
20050118246 | Wong et al. | Jun 2005 | A1 |
20050244346 | Nakao et al. | Nov 2005 | A1 |
20050249791 | Hobbs et al. | Nov 2005 | A1 |
20070116729 | Palepu | May 2007 | A1 |
20070259029 | McEntire et al. | Nov 2007 | A1 |
20080220045 | Shalaby et al. | Sep 2008 | A1 |
20080233177 | Meconi | Sep 2008 | A1 |
20090130157 | Ylitalo et al. | May 2009 | A1 |
20100022654 | Asmus et al. | Jan 2010 | A1 |
20100029779 | Street et al. | Feb 2010 | A1 |
20100081672 | Wan et al. | Apr 2010 | A1 |
20100303878 | Slager et al. | Dec 2010 | A1 |
20100322996 | Wibaux et al. | Dec 2010 | A1 |
20110067799 | Mussig et al. | Mar 2011 | A1 |
20120078155 | Bowman et al. | Mar 2012 | A1 |
20120245538 | Horstmann et al. | Sep 2012 | A1 |
20120328682 | Bardwell et al. | Dec 2012 | A1 |
20130072566 | Asmus et al. | Mar 2013 | A1 |
20130239977 | McGuire, Jr. | Sep 2013 | A1 |
20130243841 | Kommareddy et al. | Sep 2013 | A1 |
20130303656 | Wibaux et al. | Nov 2013 | A1 |
20140322299 | Wibaux | Oct 2014 | A1 |
20150056291 | Wibaux et al. | Feb 2015 | A1 |
20150367021 | Wibaux | Dec 2015 | A1 |
20160000609 | Van Holten et al. | Jan 2016 | A1 |
20160228600 | Wibaux et al. | Aug 2016 | A1 |
20170007464 | Liu et al. | Jan 2017 | A1 |
20170095431 | Andrews et al. | Apr 2017 | A1 |
20200016291 | Wibaux | Jan 2020 | A1 |
Number | Date | Country |
---|---|---|
1985043241 | Dec 1985 | AU |
1207228 | Jul 1986 | CA |
2333009 | Dec 1999 | CA |
1522687 | Aug 2004 | CN |
1961666 | May 2007 | CN |
101653431 | Feb 2010 | CN |
0066899 | Dec 1982 | EP |
0404558 | Dec 1990 | EP |
0328421 | Apr 1993 | EP |
0361722 | Dec 1993 | EP |
1139981 | Apr 2002 | EP |
1203531 | Nov 2003 | EP |
1784232 | May 2007 | EP |
3280769 | Feb 2018 | EP |
3368086 | Sep 2018 | EP |
2968014 | Apr 2019 | EP |
2274586 | Aug 1994 | GB |
1990-147063 | Jun 1990 | JP |
6-508287 | Sep 1994 | JP |
6-509955 | Nov 1994 | JP |
2825549 | Nov 1998 | JP |
2002179513 | Jun 2002 | JP |
2002-272831 | Sep 2002 | JP |
2002-332228 | Nov 2002 | JP |
2003534310 | Nov 2003 | JP |
2004010545 | Jan 2004 | JP |
2007502319 | Feb 2007 | JP |
2007-526348 | Sep 2007 | JP |
2007-536261 | Dec 2007 | JP |
2014510038 | Apr 2014 | JP |
1990013780 | Nov 1990 | WO |
WO9300118 | Jan 1993 | WO |
WO1993002717 | Feb 1993 | WO |
WO9303649 | Mar 1993 | WO |
WO1999000025 | Jan 1999 | WO |
1999023150 | May 1999 | WO |
WO992470 | Dec 1999 | WO |
WO2000036353 | Jun 2000 | WO |
WO2000061692 | Oct 2000 | WO |
2003103618 | Dec 2003 | WO |
2004080499 | Sep 2004 | WO |
2009064291 | May 2009 | WO |
WO2010080936 | Jul 2010 | WO |
2011009083 | Jan 2011 | WO |
WO2011088072 | Jul 2011 | WO |
WO2012100244 | Jul 2012 | WO |
2012158483 | Mar 2013 | WO |
WO2013074628 | May 2013 | WO |
2013090191 | Jun 2013 | WO |
2014124232 | Aug 2014 | WO |
2015188031 | Dec 2015 | WO |
2015187632 | Dec 2015 | WO |
Entry |
---|
Giunchedi, et al. “Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres,” European Journal of Pharmaceutics and Biopharmaceutics, Elsevier Science Publishers B.V., Amsterdam, NL, vol. 53, No. 2, Mar. 1, 2002, pp. 233-239, XP004342819, ISSN: 0939-6411, DOI: 10.1016/S0939-6411(01)00237-5 Section 2.2 Preparation by spray-drying; table 2. |
International Search Report and Written Opinion issued in corresponding IA No. PCT/US2012/022162 dated Aug. 10, 2012. |
Avery Dennison Medical Solutions Demonstrates the Efficacy of its new Chlorhexidine Gluconate Adhesive Delivery System, Avery Dennison Medical Solutions, Sep. 13, 2011, 1-2. |
Boddupalli, et al., Mucoadhesive drug delivery system: An overview, Jounal of Advanced Pharmaceutical Technology & Research, vol. 1, 2010, 381-387. |
Ceballos, et al., Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets, II Farmaco, Jan. 15, 2005, 913-918, vol. 60, No. 11-12. |
Cui, et al., Bilayer Films for Mucosal (Genetic) Immunization via the Buccal Route in Rabbits, Pharmaceutical Research, Jul. 2002, 947-953, vol. 19, No. 7. |
Eudragit, acrylic polymers for solid oral dosage forms, Jan. 1, 2008, 1-11. |
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US14/15263 dated Sep. 19, 2014. |
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US2015/033689 dated Sep. 8, 2015. |
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US2012/065014 dated Feb. 15, 2013. |
Invitation to Pay Additional Fees issued in corresponding IA No. PCT/US2012/022162 dated Apr. 12, 2012. |
Maruzen, “New Experimental Chemistry Course 1 Basic Operation I”, Sep. 20, 1975, 459-463. |
Yue, et al., A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease, Biomaterials, vol. 25, 2004, pp. 3743-3750. |
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US2015/034336 dated Mar. 23, 2016. |
International Search Report and Written Opinion issued in corresponding IA No. PCT/US2014/025549 dated Jul. 25, 2014. |
International Preliminary Reporton Patentability dated Sep. 24, 2015 issued in corresponding IA No. PCT/US2014/025549 filed Mar. 13, 2014. |
International Preliminary Report on Patentability dated Jul. 23, 2013 issued in corresponding IA No. PCT/US2012/022162 filed Jan. 23, 2012. |
International Search Report and Written Opinion dated Jan. 21, 2013 issued in corresponding IA No. PCT/US2012/037429 filed May 11, 2012. |
International Preliminary Report on Patentability dated Nov. 19, 2013 issued in corresponding IA No. PCT/US2012/037429 filed May 11, 2012. |
Pei, et al. “Plant Fiber Chemistry”, pp. 244-246, China Light Industry Press, Jul. 2012. |
International Preliminary Report on Patentability dated May 20, 2014 issued in corresponding IA No. PCT/US2012/065014 filed Nov. 14, 2012. |
Sateesh Kandavilli: “Polymers in Transdermal Drug Delivery Systems,” Pharmaceutical Technology, May 31, 2002, XP055101101, Retrieved from the internet: http://www.pharamtech.com/pharmtech/data/articiestandard/pharmtech/192002/18600/article.pdf [retrieved on Feb. 10, 2014]. |
Luo, et al., A Complete Collection of Pharmaceutical Excipients, Sichuan university of science and technology press, Jan. 31, 2006, 53-56. |
International Preliminary Report on Patentability dated Dec. 6, 2016 issued in corresponding IA No. PCT/US2015/034336 filed Jun. 5, 2015. |
He et al., General Practitioner's Guidelines for Medication Use, Beijing Science and Technology Press, Nov. 30, 2010, 1205. |
Yao, Application Directory of Pharmaceutical Excipients, China Medical Science and Technology Press, Aug. 31, 2011, 1342-1347. |
International Preliminary Report on Patentability dated Jul. 6, 2015 issued in corresponding IA. No. PCT/US2014/015263 filed Feb. 7, 2014. |
Invitation to Pay Additional Fees dated May 22, 2014 issued in corresponding IA No. PCT/US2014/015263 filed Feb. 7, 2014. |
International Preliminary Report on Patentability dated Dec. 15, 2016 issued in corresponding IA No. PCT/US2015/033689 filed Jun. 2, 2015. |
Polysciences, Poly(acrylic acid), 25% soln, in water [PAA ˜50,000], Retrieved Aug. 14, 2021 (Year 2021). |
Number | Date | Country | |
---|---|---|---|
20160030248 A1 | Feb 2016 | US |
Number | Date | Country | |
---|---|---|---|
61787908 | Mar 2013 | US |